{"id":56972,"date":"2024-02-27T17:16:42","date_gmt":"2024-02-27T17:16:42","guid":{"rendered":"https:\/\/medsname.com\/ezedoc\/"},"modified":"2026-08-28T11:51:18","modified_gmt":"2026-08-28T11:51:18","slug":"ezedoc","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/ezedoc\/","title":{"rendered":"Ezedoc"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Ezedoc?<\/h3>\n<p style=\"margin: 0;\"><strong>Ezedoc<\/strong> contiene <strong>ezetimibe<\/strong> (10 mg), un <strong>inhibidor de la absorci\u00f3n de colesterol<\/strong> que bloquea el transportador NPC1L1 en el intestino delgado. Es el <strong>go-to add-on therapy when a statin alone doesn\u2019t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17\u201322%. Added to a statin, it produces an additional ~20\u201325% LDL reduction, totaling a 55\u201360% fall \u2014 equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The <strong>(18.144 pacientes post-SCA) demostr\u00f3 que a\u00f1adir ezetimibe a simvastatina reduce a\u00fan m\u00e1s los eventos cardiovasculares. Dosis: 10 mg una vez al d\u00eda, en cualquier momento, con o sin alimentos. Generalmente muy bien tolerado: molestias gastrointestinales leves, mialgias ocasionales, elevaci\u00f3n poco frecuente de transaminasas. Evitar en insuficiencia hep\u00e1tica grave.<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10\u00a0mg once daily, any time, with or without food. Generally very well-tolerated \u2014 mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Fabricante certificado WHO-GMP \u00b7 Env\u00edo discreto \u00b7 Env\u00edos mundiales \u00b7 M\u00e1s de 1.400 verificados <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<h3>Por qu\u00e9 comprar en MedsBase<\/h3>\n<p>Nuestros medicamentos gen\u00e9ricos proceden de fabricantes certificados por la OMS-GMP y se env\u00edan a todo el mundo en paquetes discretos y sin marcas \u2014 sin nombres de medicamentos en el exterior. Los pagos con tarjeta se procesan a trav\u00e9s de un proveedor regulado (los descriptores de extracto incluyen un procesador de pagos regulado \u2014 nunca \u201cMedsBase\u201d ni ning\u00fan nombre de medicamento). Tambi\u00e9n se aceptan criptomonedas y transferencias bancarias SEPA. Todos los pedidos est\u00e1n respaldados por nuestra Pol\u00edtica de Reenv\u00edo Garantizado.<\/p>\n<h2 class=\"wp-block-heading\">Ezedoc es un medicamento hipolipemiante oral que contiene<\/h2>\n<p>(10 mg), fabricado por un productor certificado por la OMS-GMP. Se suministra en envases de 30, 60, 90 o 180 comprimidos. El ezetimibe es el primer y \u00fanico f\u00e1rmaco de la <strong>ezetimibe<\/strong> clase. Marca original: <strong>inhibidor de la absorci\u00f3n de colesterol<\/strong> Zetia \/ Ezetrol <strong>(Merck, 2002).<\/strong> El ezetimibe es un pilar en el manejo lip\u00eddico de segunda l\u00ednea: la primera opci\u00f3n cuando se necesita una mayor reducci\u00f3n de LDL que la que proporciona una dosis tolerada de estatina, o cuando un paciente no tolera dosis m\u00e1s altas de estatinas. Tambi\u00e9n es el compa\u00f1ero m\u00e1s com\u00fan en combinaciones a dosis fijas (simvastatina\/ezetimibe = Inegy\/Vytorin; rosuvastatina\/ezetimibe = varios).<\/p>\n<p>Ezetimibe is a mainstay of second-line lipid management \u2014 the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n<h2 class=\"wp-block-heading\">What Is Ezedoc Used For?<\/h2>\n<ul>\n<li><strong>Hipercolesterolemia primaria<\/strong> \u2014 as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose<\/li>\n<li><strong>Intolerancia a las estatinas<\/strong> \u2014 as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems<\/li>\n<li><strong>Hipercolesterolemia familiar<\/strong> (heterozygous and homozygous) \u2014 in combination with statin<\/li>\n<li><strong>Prevenci\u00f3n secundaria tras un s\u00edndrome coronario agudo<\/strong> \u2014 add to statin to further reduce CV events (IMPROVE-IT trial)<\/li>\n<li><strong>Sitosterolemia<\/strong> \u2014 a rare genetic condition where ezetimibe is disease-modifying<\/li>\n<\/ul>\n<p>Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30\u201360%); it is most powerful as an add-on.<\/p>\n<h2 class=\"wp-block-heading\">\u00bfC\u00f3mo funciona Ezedoc?<\/h2>\n<p>La ezetimiba inhibe selectivamente el <strong>transportador Niemann-Pick C1-Like 1 (NPC1L1)<\/strong> en los enterocitos del intestino delgado proximal. El NPC1L1 es responsable de absorber el colesterol diet\u00e9tico y biliar desde la luz intestinal hacia el enterocito.<\/p>\n<p>Con el NPC1L1 bloqueado:<\/p>\n<ul>\n<li><strong>La absorci\u00f3n intestinal de colesterol disminuye en ~54%<\/strong><\/li>\n<li><strong>Las reservas hep\u00e1ticas de colesterol se reducen<\/strong> porque menos colesterol llega al h\u00edgado<\/li>\n<li><strong>Los receptores de LDL se regulan al alza<\/strong> on hepatocytes \u2014 the liver pulls more LDL out of the blood<\/li>\n<li><strong>Plasma LDL-C falls by 17\u201322%<\/strong> como monoterapia; hasta un 25% adicional cuando se combina con una estatina<\/li>\n<li>La actividad de la HMG-CoA reductasa (el objetivo de las estatinas) no se modifica<\/li>\n<\/ul>\n<p>Dado que la ezetimiba y las estatinas act\u00faan sobre <strong>v\u00edas complementarias<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other\u2019s side-effect profile.<\/p>\n<p>Datos de resultados: el <strong>ensayo IMPROVE-IT<\/strong> (2015) demostr\u00f3 que a\u00f1adir ezetimiba a simvastatina en pacientes post-SCA redujo el criterio de valoraci\u00f3n combinado CV en un 6,4% (NNT 50 a lo largo de 7 a\u00f1os), confirmando que la reducci\u00f3n de LDL se traduce en una disminuci\u00f3n real de eventos.<\/p>\n<h2 class=\"wp-block-heading\">Posolog\u00eda y administraci\u00f3n<\/h2>\n<p><strong>Dosis est\u00e1ndar:<\/strong> 10\u00a0mg once daily at any time of day, with or without food.<\/p>\n<ul>\n<li>T\u00f3mese a una hora constante para mejorar la adherencia.<\/li>\n<li>Can be taken at the same time as a statin or spaced out \u2014 no timing interaction.<\/li>\n<li>Miss a dose \u2014 take it as soon as you remember unless close to the next; do not double up.<\/li>\n<li>No se requiere ajuste de dosis en insuficiencia renal o insuficiencia hep\u00e1tica leve-moderada.<\/li>\n<li>Monitor lipid panel and ALT at baseline and 6\u20138 weeks after starting. Check CK only if symptoms.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efectos secundarios<\/h2>\n<p>La ezetimiba es uno de los f\u00e1rmacos hipolipemiantes mejor tolerados. Los eventos adversos en ensayos son similares a las tasas de placebo.<\/p>\n<p><strong>Com\u00fan (&lt; 5%):<\/strong><\/p>\n<ul>\n<li>Diarrea leve, flatulencia<\/li>\n<li>Infecci\u00f3n del tracto respiratorio superior, sinusitis<\/li>\n<li>Fatiga<\/li>\n<li>Artralgia<\/li>\n<\/ul>\n<p><strong>Poco frecuentes:<\/strong><\/p>\n<ul>\n<li>Transaminase elevation \u2014 usually small; more common when combined with a statin<\/li>\n<li>Muscle pain, myalgia, myopathy \u2014 rare; primarily when combined with statin<\/li>\n<li>Hipersensibilidad, angioedema, erupci\u00f3n cut\u00e1nea<\/li>\n<li>Pancreatitis \u2014 very rare<\/li>\n<li>Cholelithiasis \u2014 very rare<\/li>\n<li>Thrombocytopenia \u2014 very rare<\/li>\n<li>Rhabdomyolysis \u2014 exceedingly rare, almost always in combination with a statin<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interacciones farmacol\u00f3gicas<\/h2>\n<ul>\n<li><strong>Ciclosporina<\/strong> \u2014 significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.<\/li>\n<li><strong>Secuestrantes de \u00e1cidos biliares<\/strong> (cholestyramine, colestipol) \u2014 reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.<\/li>\n<li><strong>Warfarina<\/strong> \u2014 occasional INR change reported; monitor when starting.<\/li>\n<li><strong>Estatinas<\/strong> \u2014 no adverse PK interaction; this combination is the therapeutic mainstay.<\/li>\n<li><strong>Fibratos<\/strong> \u2014 fenofibrate\/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u00bfQui\u00e9n no debe tomar Ezedoc?<\/h2>\n<ul>\n<li>Disfunci\u00f3n hep\u00e1tica moderada a grave (cuando se combina con una estatina)<\/li>\n<li>Active liver disease or persistent transaminase elevation &gt; 3\u00d7 ULN<\/li>\n<li>Embarazo (cuando se combina con una estatina)<\/li>\n<li>Lactancia<\/li>\n<li>Ni\u00f1os &lt; 10 a\u00f1os (datos insuficientes)<\/li>\n<li>Hipersensibilidad conocida a la ezetimiba<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Almacenamiento<\/h2>\n<p>Store Ezedoc below 25\u00b0C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3 class=\"wp-block-heading\">\u00bfPuedo tomar Ezedoc en lugar de una estatina?<\/h3>\n<p>Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% \u2014 much less than a statin (30\u201360%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n<h3 class=\"wp-block-heading\">\u00bfC\u00f3mo se compara Ezedoc con duplicar mi dosis de estatina?<\/h3>\n<p>Doubling a statin dose typically adds ~6% LDL reduction (the statin \u201crule of 6\u201d). Adding ezetimibe adds ~20\u201325% LDL reduction. <strong>Adding ezetimibe is 3\u20134\u00d7 more effective<\/strong> que duplicar la estatina, y sin el aumento de s\u00edntomas musculares relacionados con la dosis. Por eso las gu\u00edas modernas favorecen la combinaci\u00f3n de estatina + ezetimiba en lugar de aumentar la estatina a la dosis m\u00e1xima.<\/p>\n<h3 class=\"wp-block-heading\">\u00bfReduce Ezedoc los infartos y los accidentes cerebrovasculares?<\/h3>\n<p>Yes \u2014 the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n<h3 class=\"wp-block-heading\">\u00bfCu\u00e1ndo debo tomar Ezedoc?<\/h3>\n<p>Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent \u2014 pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n<h3 class=\"wp-block-heading\">\u00bfProvoca Ezedoc dolor muscular como las estatinas?<\/h3>\n<p>Raramente. La monoterapia con ezetimiba muestra efectos secundarios musculares similares al placebo. Cuando se combina con una estatina, no aumenta significativamente los s\u00edntomas musculares relacionados con las estatinas en comparaci\u00f3n con la estatina sola.<\/p>\n<h3 class=\"wp-block-heading\">\u00bfD\u00f3nde puedo comprar Ezedoc online?<\/h3>\n<p>Puede pedir Ezedoc (10 mg) en MedsBase en paquetes de 30, 60, 90 o 180 comprimidos. Enviamos a todo el mundo con embalaje discreto y stock genuino de fabricantes certificados por la OMS-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Medicamentos relacionados para el colesterol<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/es\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/pivasta\/\">Pivasta \u2014 Pitavastatin (interaction-clean)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/lipicard\/\">Lipicard \u2014 Fenofibrate (for triglycerides)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/high-cholesterol-treatments\/\"><strong>Ver todos los medicamentos para el colesterol alto<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> Esta p\u00e1gina es solo para fines informativos y no sustituye el consejo m\u00e9dico de un profesional sanitario cualificado. El dolor muscular inexplicable, el amarillamiento de la piel o los ojos, o el dolor abdominal intenso requieren una evaluaci\u00f3n m\u00e9dica inmediata.<\/div>\n<h3 class=\"wp-block-heading\">Por qu\u00e9 comprar en MedsBase<\/h3>\n<p>Ezedoc se suministra a trav\u00e9s de un fabricante certificado por la OMS-GMP con documentaci\u00f3n completa de COA. Enviamos a todo el mundo en embalaje sencillo y discreto, y cada pedido est\u00e1 cubierto por nuestro <a href=\"\/es\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. Your statement descriptor when paying by card shows the regulated payment processor (a regulated card-payment processor), never \u201cMedsBase\u201d or any medication name.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternativas relacionadas<\/h3>\n<p>Otros productos en <strong>Enfermedades cr\u00f3nicas<\/strong> que los clientes tambi\u00e9n ven:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/es\/bencid\/\">Bencid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/tiova-rotacaps\/\">Tiova Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/serobid-rotacaps\/\">Serobid Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/headset\/\">Headset<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/es\/xafinact\/\">Xafinact<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reduce los niveles de colesterol<br \/>\n\u2705 Reduce el Riesgo de Enfermedad Card\u00edaca<br \/>\n\u2705 Previene la Aterosclerosis<br \/>\n\u2705 Recetado por m\u00e9dicos<br \/>\n\u2705 Opci\u00f3n de medicaci\u00f3n oral<\/p>\n<p><strong>Ezedoc<\/strong> contiene <strong>Ezetimiba<\/strong>.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}